Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Details on Person Laird, A Douglas

Class:Id	Person:9652248
_displayName	Laird, A Douglas
_timestamp	2019-06-28 18:11:00
created	[InstanceEdit:9652267] Orlic-Milacic, Marija, 2019-06-28
firstname	A Douglas
initial	AD
surname	Laird
(author)	[LiteratureReference:9652237] Inhibition of the T790M gatekeeper mutant of the epidermal growth factor receptor by EXEL-7647 [LiteratureReference:9674233] In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: determination of a pharmacokinetic/pharmacodynamic relationship [LiteratureReference:9736183] Cabozantinib (XL184), a novel MET and VEGFR2 inhibitor, simultaneously suppresses metastasis, angiogenesis, and tumor growth
[Change default viewing format]

No pathways have been reviewed or authored by Laird, A Douglas (9652248)